The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CMPX FINANCIAL STATEMENTS

Compass Therapeutics Inc. — balance sheet, income statement and cash flow trends

CMPXCompass Therapeutics Inc.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-75 M-50 M-25 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-738 K $ · -Infinity%Operating Income-81.1 M $ · -Infinity%Pre-tax Income-73.4 M $ · -Infinity%Net Income to Owners-73.4 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-738 K $—
Operating Income-81.1 M $—
EBITDA-72.7 M $—
Net Income to Owners-73.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets190.2 M
  • Equity166 M $87%
  • Current Liabilities16.1 M $8%
  • Long-term Liabilities8 M $4%

Key Figures

YoY change
Total Assets190.2 M $+63.0%
Total Liabilities24.1 M $+2.7%
Total Equity166 M $+78.2%
Cash & ST Investments179.9 M $+78.2%
Total Debt9.6 M $-2.7%
Net Debt-25.8 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-54.8 M $Operating-65.1 M $Investing129.9 M $Financing10.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-54.8 M $—
Capital Expenditures265 K $+327.4%
Free Cash Flow-55.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CMPX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.